ArticleJournal of shoulder and elbow arthroplasty2026
Mid- and long-term results of primary vs. secondary total elbow arthroplasty after index intra-articular fracture of the distal humerus in the elderly.
Article in Journal of shoulder and elbow arthroplasty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Geriatric distal humerus fractures are difficult to manage. Open reduction and internal fixation remain the standard, but total elbow arthroplasty (TEA) appears to be a viable alternative. This study evaluated the long-term outcome after primary TEA in comparison to secondary TEA. Methods: In this retrospective cohort study with prospective follow-up (FU), patients undergoing TEA after complex distal humerus fractures were analyzed as either primary TEA (index treatment; n = 21) or secondary TEA (salvage procedure after failed fracture treatment; n = 13). Data extracted from the medical records and the final clinical FU included demographics, fracture type, Mayo Elbow Performance Score, Disabilities of the Arm, Shoulder and Hand, patient satisfaction, range of motion (flexion-extension and pronation-supination), normalized handgrip strength, Janda muscle strength grades (flexion, extension, pronation, supination), complications, and revisions. Results: From 2003 to 2012, 57 TEAs were performed; 34 patients with semiconstrained prosthesis models met the study criteria and were available for analysis (21 primary, 13 secondary; 7 men, 27 women). The remaining 23 cases were excluded because of non-post-traumatic indications, prosthesis types outside the inclusion criteria, or unavailable analyzable FU of at least 5 years. Mean FU was 8 years (range, 5-13). Mean age at surgery was 62 ± 15 years (23-85), with no difference between primary and secondary TEA ( Conclusion: In this Level III retrospective cohort comparison, primary TEA was associated with better mid- to long-term functional scores and patient satisfaction than secondary TEA. However, several clinically relevant numerical differences, including range of motion, complication rate, and revision rate, did not reach statistical significance and should be interpreted cautiously in light of the limited sample size, retrospective design, and potential selection bias. Prospective multicenter studies and registry data are needed to refine indications and long-term expectations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.